Ticker	Volume	Price	Price Delta
DJIA	12,454.80	-74.92	-0.60%
S&P 500	1,317.82	-2.86	-0.22%
Nasdaq	2,837.53	-1.85	-0.07%

Ticker

Volume

Price

Price Delta

DJIA

12,454.80

-74.92

-0.60%

S&P 500

1,317.82

-2.86

-0.22%

Nasdaq

2,837.53

-1.85

-0.07%

Ticker	Volume	Price	Price Delta
STOXX 50	2,161.87	+5.35	0.25%
FTSE 100	5,351.53	+1.48	0.03%
DAX	6,339.94	+24.05	0.38%

Ticker

Volume

Price

Price Delta

STOXX 50

2,161.87

+5.35

0.25%

FTSE 100

5,351.53

+1.48

0.03%

DAX

6,339.94

+24.05

0.38%

Ticker	Volume	Price	Price Delta
Nikkei	8,580.39	+17.01	0.20%
TOPIX	722.11	-0.14	-0.02%
Hang Seng	18,713.40	+47.01	0.25%

Ticker

Volume

Price

Price Delta

Nikkei

8,580.39

+17.01

0.20%

TOPIX

722.11

-0.14

-0.02%

Hang Seng

18,713.40

+47.01

0.25%

UCB First-Half Earnings Rise 9.6%, Beating Analyst Estimates; Sales Climb

By John Martens - 2010-08-02T05:10:54Z

UCB SA, Belgium’s biggest drugmaker, reported first-half earnings before interest, tax, depreciation, amortization and one-time items rose to 398 million euros from 363 million euros, according to a statement on its website. Analysts had seen Ebitda ex-items of 381.4 million euros. Sales rose to 1.64 billion euros from 1.6 billion euros.